NEUROTECH PHARMACEUTICALS
Neurotech Pharmaceuticals, Inc. is a Cumberland-based biotech business that is privately held. Encapsulated Cell Technology (ECT) is a patented delivery technology platform developed by Neurotech to provide therapeutic elements for the treatment of retinal disorders. Renexus®, the company's principal programme, is being tested in the orphan illness macular telangiectasia (MacTel) as well as glaucoma. In 2017, the company plans to start a Phase III research in MacTel. Neurotech has created genetically-engineered cell lines to produce a therapeutic protein.
NEUROTECH PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Hospital Medical Pharmaceutical Wellness
Founded:
1995-01-01
Address:
Cumberland, Rhode Island, United States
Country:
United States
Website Url:
http://www.neurotechusa.com
Total Employee:
11+
Status:
Active
Contact:
+1 401 333 3880
Similar Organizations
Airix
Airix is a technology and design to improve healthcare delivery for patients.
Artemetrx
PSG is a intelligence and technology company providing cutting-edge drug cost-management solutions.
FabGennix
FabGennix is a biotechnology company providing antibodies, reagents, and kits to the scientific community.
Infusion Center of Pennsylvania
Infusion Center of Pennsylvania provides healthcare services.
The Family Doctor
The Family Doctor provides trustworthy and affordable healthcare for families.
Official Site Inspections
http://www.neurotechusa.com
- Host name: 209.17.116.163
- IP address: 209.17.116.163
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Neurotech Pharmaceuticals"
Neurotech - Crunchbase Company Profile & Funding
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases. View contacts for Neurotech to access new leads and connect with decision-makers.See details»
Neurotech Pharmaceuticals, Inc. - Encapsulated Cell Therapy
Jun 20, 2024 · Neurotech is a private clinical stage biotech company focused on developing transformative therapies for chronic eye disease. The core platform technology, Encapsulated …See details»
Neurotech USA, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neurotech USA, Inc. of Cumberland, RI. Get the latest business insights from Dun & Bradstreet.See details»
Neurotech Pharmaceuticals, Inc. - Lincoln, RI, USA
Oct 17, 2005 · Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has developed a proprietary delivery technology …See details»
Encapsulated Cell Therapy | Contact Neurotech Pharmaceuticals
Do you have questions about our work? Contact the experts at Neurotech Pharmaceuticals, Inc, Located in Cumberland, RI.See details»
Neurotech Pharmaceuticals, Inc. Granted Fast Track ... - BioSpace
Feb 12, 2019 · Neurotech Pharmaceuticals, Inc. is a private biotechnology company focused on developing transformative therapies for chronic eye diseases. The core technology platform, …See details»
Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation …
Feb 12, 2019 · Neurotech Pharmaceuticals, Inc. is a private biotechnology company focused on developing transformative therapies for chronic eye diseases. The core technology platform, …See details»
Neurotech Provides Update on BLA for NT-501 as a Treatment for …
Nov 8, 2024 · NT-501 leverages our ECT platform to deliver CNTF for the treatment of chronic retinal diseases, such as MacTel. CNTF is a potent neuroprotective protein that promotes the …See details»
Neurotech Company Profile - Craft
See insights on Neurotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Neurotech Pharmaceuticals, Inc. Receives Priority Review of …
CUMBERLAND, R.I., June 20, 2024 -- (BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., an innovator in sustained drug delivery for chronic retinal diseases, announces that the U.S. Food …See details»
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance ...
CUMBERLAND, R.I., Sept. 19, 2013 /PRNewswire/ -- Neurotech Pharmaceuticals, a biotechnology company developing sight-saving therapies for chronic retinal disease, …See details»
Neurotech Announces the Opening of Its GMP Manufacturing
CUMBERLAND, R.I., Oct. 21 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic …See details»
Neurotech Pharmaceuticals, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Alex Gorsky Joins Neurotech’s Board as Lead Director
Sep 13, 2023 · Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.See details»
Neurotech Pharmaceuticals, Inc. and Lowy Medical Research …
Jan 16, 2019 · LMRI supports MacTel type 2 clinical and laboratory research and collaborated with Neurotech to test NT-501 in MacTel type 2 patients. The NT-501, or Renexus® device, is …See details»
Alex Gorsky Joins Neurotech’s Board as Lead Director
Sep 13, 2023 · Neurotech Pharmaceuticals, Inc. is a private clinical stage biotech company focused on developing transformative therapies for chronic eye diseases. The core platform …See details»
News | Press Releases | Neurotech Pharmaceuticals, Inc
Nov 2, 2022 · Learn more and get updates on Neurotech Pharmaceuticals corporate and how we deliver MacTel treatment solutions.See details»
Encapsulated cell technology delivery of ciliary neurotrophic factor ...
Jul 30, 2021 · Neurotech Pharmaceuticals, Inc. has created genetically engineered cell lines that can be customized to produce various therapeutic proteins through its proprietary …See details»
Neurotech Granted Fast Track Designations from the FDA for
Sep 3, 2008 · To learn more about Neurotech and the clinical studies of NT-501, please visit our web site at http://www.neurotechusa.com. CONTACT: Rich Small, Vice President, CFO of …See details»
Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) …
Jun 20, 2017 · NT-501 utilizes the Company's proprietary Encapsulated Cell Therapy (ECT) platform that can be customized to deliver specific therapeutic molecules to the back of the …See details»